MedPath

Multicenter prospective randomized trial of aneurysm sac side branch embolization during endovascular aneurysm repair

Not Applicable
Conditions
Abdominal Aortic Aneurysm
Registration Number
JPRN-UMIN000051653
Lead Sponsor
agoya University
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending
Sex
All
Target Recruitment
90
Inclusion Criteria

Not provided

Exclusion Criteria

Patients whose all lumbar arteries at the aneurysm site are occluded. Subjects with systemic conditions or advanced malignancies that are expected to have a life expectancy of less than 1 year. Patients with known hereditary diseases such as Marfan syndrome or Ehlers-Danlos syndrome Infected aortic aneurysm Isolated iliac artery aneurysm Patients with isolated iliac artery aneurysm, isolated iliac artery aneurysm, cystic aneurysm, or PAU (penetrating atherosclerotic ulcer). Patients with severe allergy to iodine contrast media who cannot use contrast media Patients with renal impairment with preoperative eGFR less than 30 ml/min/1.73 m2 and not on dialysis Women who are pregnant, possibly pregnant, within 28 days postpartum, or lactating.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
One-year aneurysm sac shrinkage after EVAR
Secondary Outcome Measures
NameTimeMethod
Two- / Three-year sac shrinkage after EVAR, Incidence of type II endoleaks, Overall survival, Freedom from aneurysm-related death, Freedom from re-intervention
© Copyright 2025. All Rights Reserved by MedPath